ATE445396T1 - 3-arylthioindol-2-carbonsäureamidderivate und ihre analoge als hemmer von caseinkinase i - Google Patents

3-arylthioindol-2-carbonsäureamidderivate und ihre analoge als hemmer von caseinkinase i

Info

Publication number
ATE445396T1
ATE445396T1 AT05785433T AT05785433T ATE445396T1 AT E445396 T1 ATE445396 T1 AT E445396T1 AT 05785433 T AT05785433 T AT 05785433T AT 05785433 T AT05785433 T AT 05785433T AT E445396 T1 ATE445396 T1 AT E445396T1
Authority
AT
Austria
Prior art keywords
caseinkinase
arylthioindole
analogues
inhibitors
acid amide
Prior art date
Application number
AT05785433T
Other languages
English (en)
Inventor
William Arthur Metz
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Application granted granted Critical
Publication of ATE445396T1 publication Critical patent/ATE445396T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
AT05785433T 2004-08-19 2005-08-19 3-arylthioindol-2-carbonsäureamidderivate und ihre analoge als hemmer von caseinkinase i ATE445396T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60334804P 2004-08-19 2004-08-19
PCT/US2005/029306 WO2006023590A1 (en) 2004-08-19 2005-08-19 3-ARYLTHIOINDOLE-2-CARBOXAMIDE DERIVATIVES AND ANALOGS THEREOF AS INHIBITORS OF CASEIN KINASE Iϵ

Publications (1)

Publication Number Publication Date
ATE445396T1 true ATE445396T1 (de) 2009-10-15

Family

ID=35311784

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05785433T ATE445396T1 (de) 2004-08-19 2005-08-19 3-arylthioindol-2-carbonsäureamidderivate und ihre analoge als hemmer von caseinkinase i

Country Status (19)

Country Link
US (1) US8008340B2 (de)
EP (1) EP1791537B1 (de)
JP (1) JP4931814B2 (de)
KR (1) KR20070045264A (de)
CN (1) CN101039666A (de)
AT (1) ATE445396T1 (de)
AU (1) AU2005277460A1 (de)
BR (1) BRPI0514397A (de)
CA (1) CA2577511A1 (de)
DE (1) DE602005017162D1 (de)
DK (1) DK1791537T3 (de)
ES (1) ES2334927T3 (de)
IL (1) IL181155A0 (de)
MX (1) MX2007001077A (de)
PL (1) PL1791537T3 (de)
PT (1) PT1791537E (de)
RU (1) RU2391098C2 (de)
SI (1) SI1791537T1 (de)
WO (1) WO2006023590A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110172244A1 (en) * 2008-02-22 2011-07-14 Irm Llc Compounds and compositions as modulators of gpr119 activity
JP4748823B2 (ja) * 2009-02-12 2011-08-17 株式会社ファルマデザイン カゼインキナーゼ1δ及びカゼインキナーゼ1ε阻害剤
JP5784620B2 (ja) * 2009-10-28 2015-09-24 ファイザー・インク カゼインキナーゼ阻害剤としてのイミダゾール誘導体
BR112012028055A2 (pt) * 2010-05-06 2019-09-24 Merck Sharp & Dohme composto, uso do mesmo, composição farmacêutica, e, métodos de tratar uma doença mediada
AU2011290238B8 (en) * 2010-08-09 2015-09-03 Nb Health Laboratory Co. Ltd. Inhibitor of casein kinase 1delta and casein kinase 1E
KR101350077B1 (ko) * 2010-12-13 2014-01-14 한국화학연구원 신규한 3-인돌리논 유도체 및 이를 포함하는 조성물
JP5937102B2 (ja) * 2010-12-14 2016-06-22 エレクトロフォレティクス リミテッド カゼインキナーゼ1デルタ(ck1デルタ)阻害剤
NZ728724A (en) * 2012-05-11 2018-03-23 Reset Therapeutics Inc Carbazole-containing sulfonamides as cryptochrome modulators
TWI690521B (zh) 2014-04-07 2020-04-11 美商同步製藥公司 作為隱花色素調節劑之含有咔唑之醯胺類、胺基甲酸酯類及脲類
WO2018133835A1 (en) * 2017-01-20 2018-07-26 National Institute Of Biological Sciences, Beijing Nucleoside analogue regulating mammalian circadian rhythm

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3705934A1 (de) * 1987-02-25 1988-09-08 Nattermann A & Cie Indolyl-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EP0686148A4 (de) * 1993-02-24 1996-02-07 Merck & Co Inc Inhibitoren der hiv inversen transcriptase
US5807693A (en) * 1994-11-23 1998-09-15 Icos Corporation Calcineurin inhibitory compounds and anchoring protein
AU767800B2 (en) * 1999-06-08 2003-11-27 Aventisub Ii Inc. Screening methods for altering circadian rhythm proteins
JP2005526090A (ja) * 2002-03-13 2005-09-02 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 神経伝達物質調節因子としてのピラゾロ(1,5−a)ピリジン誘導体
WO2004005501A1 (en) * 2002-07-08 2004-01-15 Bayer Healthcare Ag Regulation of human casein kinase i epsilon
WO2004014300A2 (en) * 2002-08-09 2004-02-19 Merck & Co., Inc. Tyrosine kinase inhibitors
JP4691506B2 (ja) * 2003-12-11 2011-06-01 アベンティス・ファーマスーティカルズ・インコーポレイテツド カゼインキナーゼIεの阻害剤としての置換1H−ピロロ[3,2−b,3,2−c,及び2,3−c]ピリジン−2−カルボキシアミド及び関連類似物

Also Published As

Publication number Publication date
ES2334927T3 (es) 2010-03-17
WO2006023590A1 (en) 2006-03-02
BRPI0514397A (pt) 2008-06-10
AU2005277460A1 (en) 2006-03-02
PT1791537E (pt) 2010-01-19
JP2008510704A (ja) 2008-04-10
KR20070045264A (ko) 2007-05-02
DE602005017162D1 (de) 2009-11-26
US8008340B2 (en) 2011-08-30
IL181155A0 (en) 2007-07-04
PL1791537T3 (pl) 2010-04-30
EP1791537A1 (de) 2007-06-06
SI1791537T1 (sl) 2010-02-26
RU2391098C2 (ru) 2010-06-10
JP4931814B2 (ja) 2012-05-16
US20070142454A1 (en) 2007-06-21
MX2007001077A (es) 2007-04-17
DK1791537T3 (da) 2010-03-01
RU2007109813A (ru) 2008-09-27
CN101039666A (zh) 2007-09-19
CA2577511A1 (en) 2006-03-02
EP1791537B1 (de) 2009-10-14

Similar Documents

Publication Publication Date Title
EA201101672A1 (ru) Замещенные производные аминомасляной кислоты в качестве ингибиторов неприлизина
EA200900152A1 (ru) Ингибиторы пирролотриазинкиназы
WO2007056517A3 (en) Pharmaceutical salts and polymorphs of n- (5-chl0r0-2-pyridinyl) -2- [ [4- [ (dimethylamino) iminomethyl] benzoyl] amino] -5-meth oxy-benzamide, a factor xa inhibitor
IL181155A0 (en) 3-arylthioindole-2-carboxamide derivatives and analogs thereof as inhibitors of casein kinase i?á
EA201070167A1 (ru) Замещенные производные индазола, активные как ингибиторы киназы
EA201101671A1 (ru) Замещенные производные аминопропионовой кислоты в качестве ингибиторов неприлизина
TNSN06411A1 (en) Pyrimidine urea derivatives as kinase inhibitors
EA200970611A1 (ru) Замещенные пиразолохиназолиновые производные, способ их получения и их применение в качестве ингибиторов киназы
IL198979A (en) Enzyme inhibitors diacylglycerol o-acetyltransferase type 1
NZ593295A (en) Preparation method of dihydroindene amide compounds, their pharmaceutical compositions containing compounds thereof and use as protein kinase inhibitor
NO20091590L (no) Heterocykliske amidforbindelser anvendbare som kinaseinhibitorer
DK1539700T3 (da) 8-hydroxyquinolin-derivater
ATE307810T1 (de) Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren
WO2004001059A3 (en) Heterocyclic inhibitors of kinases
AU2009258496A8 (en) Sulfur-containing heterocyclic derivative having beta-secretase-inhibiting activity
TW200728307A (en) Novel spirochromanone derivatives
MY144232A (en) 5-substituted-2-phenylamino benzamides as mek inhibitors
SE0400284D0 (sv) Novel compounds
WO2006007378A3 (en) Pyrrolotriazine kinase inhibitors
MX2009011059A (es) Aminopirimidinas utiles como inhibidores de cinasas.
ATE404536T1 (de) Substituierte chinolinderivate als inhibitoren von mitotischem kinesin
MX2007004248A (es) Derivados heterociclicos de bisarilurea sustituidos como inhibidores de cinasa.
UA97348C2 (en) HETEROCYCLIC NF-kB INHIBITORS
EA200901474A1 (ru) Соли [4-(6-фтор-7-метиламино-2,4-диоксо-1,4-дигидро-2н-хиназолин-3-ил)фенил]-5-хлортиофен-2-илсульфонилмочевины в различных кристаллических формах и фармацевтические композиции на их основе
ATE373636T1 (de) Amidderivate als inhibitoren der enzymatischen aktivität von renin

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1791537

Country of ref document: EP

REN Ceased due to non-payment of the annual fee